Rational Design and Synthesis of Potent Dibenzazepine Motifs as β-Secretase Inhibitors

被引:39
作者
Al-Tel, Taleb H. [1 ]
Al-Qawasmeh, Raed A. [2 ]
Schmidt, Marco F. [3 ]
Al-Aboudi, Amal [2 ]
Rao, Shashidhar N. [4 ]
Sabri, Salim S. [1 ]
Voelter, Wolfgang [5 ]
机构
[1] Univ Sharjah, Coll Pharm, Sharjah, U Arab Emirates
[2] Univ Jordan, Dept Chem, Amman 1194, Jordan
[3] Leibniz Inst Mol Pharmacol FMP, D-13125 Berlin, Germany
[4] Schrodinger, New York, NY 10036 USA
[5] Univ Tubingen, Interfak Inst Biochem, D-72076 Tubingen, Germany
关键词
ALZHEIMERS-DISEASE; BACE1; INHIBITORS; DISCOVERY; PROGRESS; DRUG;
D O I
10.1021/jm9008482
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
We have identified small-molecule dibenzazepine. inhibitors of beta-secretase (BACE1). These BACE1 inhibitors possess two key salient features. The first is a seven-membered heterocyclic ring fused to two aromatic rings representing the P3-P2 residues. The second is an amide and/or amide bioisostere representing the P1' residue. Rational optimization led to the identification of potent analogues, such as 10 (K-1 = 211 nM).
引用
收藏
页码:6484 / 6488
页数:5
相关论文
共 19 条
[1]   Venlafaxine versus clomipramine in the treatment of obsessive-compulsive disorder: A preliminary single-blind, 12-week, controlled study [J].
Albert, U ;
Aguglia, E ;
Maina, G ;
Bogetto, F .
JOURNAL OF CLINICAL PSYCHIATRY, 2002, 63 (11) :1004-1009
[2]   Age-related cognitive decline, mild cognitive impairment or preclinical Alzheimer's disease? [J].
Celsis, P .
ANNALS OF MEDICINE, 2000, 32 (01) :6-14
[3]   Second generation of hydroxyethylamine BACE-1 inhibitors: Optimizing potency and oral bioavailability [J].
Charrier, Nicolas ;
Clarke, Brian ;
Cutler, Leanne ;
Demont, Emmanuel ;
Dingwall, Colin ;
Dunsdon, Rachel ;
East, Philip ;
Hawkins, Julie ;
Howes, Colin ;
Hussain, Ishrut ;
Jeffrey, Phil ;
Maile, Graham ;
Matico, Rosalie ;
Mosley, Julie ;
Naylor, Alan ;
O'Brien, Alistair ;
Redshaw, Sally ;
Rowland, Paul ;
Soleil, Virginie ;
Smith, Kathrine J. ;
Sweitzer, Sharon ;
Theobald, Pam ;
Vesey, David ;
Walter, Daryl S. ;
Wayne, Gareth .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (11) :3313-3317
[4]   β-Secretase (BACE1) Inhibitors from Perilla frutescens var. acuta [J].
Choi, Sun-Ha ;
Hur, Jong-Moon ;
Yang, Eun-Ju ;
Jun, Mira ;
Park, Hyo-Jun ;
Lee, Kyung-Bok ;
Moon, Eunho ;
Song, Kyung-Sik .
ARCHIVES OF PHARMACAL RESEARCH, 2008, 31 (02) :183-187
[5]   Rational design of novel, potent piperazinone and imidazolidinone BACE1 inhibitors [J].
Cumming, J. N. ;
Le, T. X. ;
Babu, S. ;
Carroll, C. ;
Chen, X. ;
Favreau, L. ;
Gaspari, P. ;
Guo, T. ;
Hobbs, D. W. ;
Huang, Y. ;
Iserloh, U. ;
Kennedy, M. E. ;
Kuvelkar, R. ;
Li, G. ;
Lowrie, J. ;
McHugh, N. A. ;
Ozgur, L. ;
Pan, J. ;
Parker, E. M. ;
Saionz, K. ;
Stamford, A. W. ;
Strickland, C. ;
Tadesse, D. ;
Voigt, J. ;
Wang, L. ;
Wu, Y. ;
Zhang, L. ;
Zhang, Q. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (11) :3236-3241
[6]   Drug therapy - Alzheimer's disease [J].
Cummings, JL .
NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (01) :56-67
[7]  
Durham TB, 2006, CURR OPIN DRUG DISC, V9, P776
[8]   Memapsin 2 (Beta-Secretase) inhibitor drug, between fantasy and reality [J].
Ghosh, Arun K. ;
Bilcer, Geoffrey ;
Hong, Lin ;
Koelsch, Gerald ;
Tang, Jordan .
CURRENT ALZHEIMER RESEARCH, 2007, 4 (04) :418-422
[9]   Discovery of an orally efficaceous 4-phenoxypyrrolidine-based BACE-1 inhibitor [J].
Iserloh, U. ;
Pan, J. ;
Stamford, A. W. ;
Kennedy, M. E. ;
Zhang, Q. ;
Zhang, L. ;
Parker, E. M. ;
McHugh, N. A. ;
Favreau, L. ;
Strickland, C. ;
Voigt, J. .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2008, 18 (01) :418-422
[10]   VISUALIZATION OF A-BETA-42(43) AND A-BETA-40 IN SENILE PLAQUES WITH END-SPECIFIC A-BETA MONOCLONALS - EVIDENCE THAT AN INITIALLY DEPOSITED SPECIES IS A-BETA-42(43) [J].
IWATSUBO, T ;
ODAKA, A ;
SUZUKI, N ;
MIZUSAWA, H ;
NUKINA, N ;
IHARA, Y .
NEURON, 1994, 13 (01) :45-53